Digital Look

Welcome to Digital Look++,
you are not logged in

AstraZeneca (AZN)

Pharma and Biotech

11,352.00p

	31-Dec-23		31-Dec-22		31-Dec-21		31-Dec-20		31-Dec-19
Revenue
Asia, Africa & Australasia	n/a	n/a	n/a	n/a	12,323.00	33%	9,728.00	37%	9,073.00	37%
Continental Europe	n/a	n/a	n/a	n/a	7,827.00	21%	4,836.00	18%	4,162.00	17%
Rest of Europe	9,725.00	21%	8,909.00	20%	n/a	n/a	n/a	n/a	n/a	n/a
The Americas	n/a	n/a	19,619.00	44%	14,022.00	37%	10,312.00	39%	9,327.00	38%
UK	3,368.00	7%	3,117.00	7%	3,245.00	9%	1,741.00	7%	1,822.00	7%
Unanalysed	32,718.00	71%	12,706.00	29%	n/a	n/a	n/a	n/a	n/a	n/a
Total	45,811.00	100%	44,351.00	100%	37,417.00	100%	26,617.00	100%	24,384.00	100%

Profit Before Tax
Asia, Africa & Australasia	n/a	n/a	n/a	n/a	931.00	n/a	745.00	19%	n/a	n/a
Continental Europe	n/a	n/a	n/a	n/a	2,682.00	n/a	2,356.00	60%	n/a	n/a
Rest of Europe	4,999.00	n/a	2,709.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a
The Americas	n/a	n/a	(1,140.00)	n/a	(2,401.00)	n/a	297.00	8%	n/a	n/a
UK	(577.00)	n/a	272.00	n/a	(1,477.00)	n/a	518.00	13%	n/a	n/a
Unanalysed	2,477.00	n/a	660.00	n/a	n/a	n/a	n/a	n/a	1,548.00	100%
Total	6,899.00	n/a	2,501.00	n/a	(265.00)	n/a	3,916.00	100%	1,548.00	100%

	31-Dec-23		31-Dec-22		31-Dec-21		31-Dec-20		31-Dec-19
Revenue
Cardiovascular, Renal & Metabolism	10,585.00	23%	9,188.00	18%	n/a	n/a	n/a	n/a	n/a	n/a
Cardiovascular, Renal and Metabolism	n/a	n/a	9,188.00	18%	8,088.00	22%	7,096.00	27%	n/a	n/a
Covid-19	n/a	n/a	n/a	n/a	n/a	n/a	2.00	n/a	n/a	n/a
Oncology	17,145.00	39%	14,631.00	28%	12,940.00	37%	10,850.00	47%	n/a	n/a
Other	1,176.00	3%	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Others	n/a	n/a	1,625.00	3%	n/a	n/a	n/a	n/a	n/a	n/a
Rare Disease	7,764.00	18%	7,053.00	14%	3,110.00	9%	n/a	n/a	n/a	n/a
Respiratory & Immunology	6,107.00	14%	5,765.00	11%	6,034.00	17%	5,357.00	23%	n/a	n/a
Unanalysed	2,022.00	n/a	(7,835.00)	n/a	2,580.00	n/a	3,312.00	n/a	n/a	n/a
Vaccines & Immune Therapies	1,012.00	2%	4,736.00	9%	4,665.00	13%	n/a	n/a	n/a	n/a
Total	45,811.00	100%	44,351.00	100%	37,417.00	100%	26,617.00	100%	24,384.00	n/a

Profit Before Tax
Unanalysed	6,899.00	n/a	2,501.00	n/a	(265.00)	n/a	3,916.00	n/a	n/a	n/a
Total	6,899.00	n/a	2,501.00	n/a	(265.00)	n/a	3,916.00	n/a	1,548.00	n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.